Global Research Antibodies Market By Product Type (Primary Antibodies and Secondary Antibodies), By Antibody Type (Monoclonal Antibodies, Polyclonal Antibodies and Recombinant Antibodies), By Source (Mouse, Rabbit, Goat and Others), By Technology (Western Blotting, Immunohistochemistry, Flow Cytometry, ELISA, Immunofluorescence, Immunoprecipitation and Others), By Research Area (Immunology, Oncology, Neuroscience, Infectious Disease, Cell and Molecular Biology, Stem Cell and Others), By End-User (Academic & Research Institutes, Pharmaceutical and Biotechnology Companies, CROs and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Jan 2026
- Report ID: 173095
- Number of Pages: 356
- Format:
-
keyboard_arrow_up
-
-
- Abcam Plc. (Acquired by Danaher)
- Thermo Fisher Scientific, Inc.
- PerkinElmer, Inc. (Now Revvity)
- Merck KGaA
- Santa Cruz Biotechnology Inc.
- Cell Signaling Technology, Inc.
- Proteintech Group, Inc.
- Becton, Dickinson and Company (BD)
- Bio-Techne Corporation
- Jackson ImmunoResearch Inc.
- GenScript Biotech Corp.
- Agilent Technologies, Inc.
- Promega Corporation
- Lonza Group Ltd.
- Qiagen
- Revvity
Our Clients
Kickstart 2026 with Exclusive Savings
✖
Request a Sample Report
We'll get back to you as quickly as possible